Scientific article
OA Policy
English

Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination

Errata
  • The original version of this Article contained an error in the spelling of a member of the VSV-EBOVAC and VSV-EBOPLUS Consortia, Ali M. Harandi, which was incorrectly given as Ali Harandi.
  • DOI : 10.1038/s41541-020-00244-w
  • PMID : 33083028
Published inNPJ Vaccines, vol. 5, 32
Publication date2020-04-14
Abstract

The rVSV-ZEBOV Ebolavirus vaccine confers protection within days after immunization, suggesting the contribution of innate immune responses. We report modulation of rVSV-ZEBOV vaccinee blood CD56+ NK cell numbers, NKG2D or NKp30 surface receptor expression, Killer Immunoglobulin-like Receptor (KIR)+ cell percentages and NK-cell-related genes on day 1 post immunization. Inverse correlations existed between the concentration of several plasma cytokines and inhibitory KIR+ CD56dim or cytokine-responsive CD56bright NK cells. Thus, NK cells may contribute to the early protective efficacy of rVSV-ZEBOV in humans.

Citation (ISO format)
PEJOSKI, David et al. Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination. In: NPJ Vaccines, 2020, vol. 5, p. 32. doi: 10.1038/s41541-020-0179-4
Main files (1)
Article (Published version)
Secondary files (1)
Supplemental data
Updates (1)
Corrigendum
accessLevelPublic
Identifiers
Additional URL for this publicationhttps://www.nature.com/articles/s41541-020-0179-4
Journal ISSN2059-0105
481views
142downloads

Technical informations

Creation04/02/2021 09:59:00
First validation04/02/2021 09:59:00
Update04/04/2025 13:02:02
Status update14/11/2024 14:50:33
Last indexation04/04/2025 13:03:46
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack